glutathione inhibitor bso Buthionine sulfoximine Combined inhibition of de novo
Description
C-Reactive protein: pathophysiology, diagnosis, false test results and a novel diagnostic algorithm for clinicians
Curr Mol Med 3, 56172.
R.AbramowiczA.Adamiec-OrganiciokM.KarnasE.Mielaczyk.KaniaD.et al (2023)
Most clients begin with one injection per week for 4 to 8 weeks
Van der Sluis M, De Koning BA, De Bruijn AC, Velcich A, Meijerink JP, Van Goudoever JB, et al
Efficacy and safety of AM-111 in the treatment of acute sensorineural hearing loss: a double-blind, randomized, placebo-controlled phase II study
